Tierney, C., Bazou, D., Majumder, M. M., Anttila, P., Silvennoinen, R., Heckman, C. A., . . . O’Gorman, P. (2021). Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients. Nature Portfolio.
Style de citation Chicago (17e éd.)Tierney, Ciara, Despina Bazou, Muntasir M. Majumder, Pekka Anttila, Raija Silvennoinen, Caroline A. Heckman, Paul Dowling, et Peter O’Gorman. Next Generation Proteomics with Drug Sensitivity Screening Identifies Sub-clones Informing Therapeutic and Drug Development Strategies for Multiple Myeloma Patients. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Tierney, Ciara, et al. Next Generation Proteomics with Drug Sensitivity Screening Identifies Sub-clones Informing Therapeutic and Drug Development Strategies for Multiple Myeloma Patients. Nature Portfolio, 2021.